The PERP Act, sorry, I mean PREP, established immunity for the Public Health Industrial Complex from responsibility for treating COVID-19—a sort of secular ‘papal’ dispensation for sins to be committed. A man suing in Michigan has been granted an exception.
In a groundbreaking decision, a Michigan judge ruled on Aug. 8 that a drug manufacturer and hospital are not protected by the Public Readiness and Emergency Preparedness (PREP) Act in the case of a man who experienced two strokes and a leg amputation after receiving the COVID-19 medication remdesivir that was contaminated with glass particles.
Willful misconduct is not protected by PERP (sorry, PREP), which ought to cast a wide net given how much the FDA, CDC, and others knew about risks associated with the alleged “treatments” and protocols (as evidenced in documents pried from their greedy hands). But that remains to be seen.
As for Dan Nowacki, his family’s fight has just begun, and the “misconduct” is more a matter of negligence and poor quality control.
According to the complaint (pdf) obtained by The Epoch Times, Mr. Nowacki, on Nov. 10, 2021, was admitted to St. Joseph Mercy Chelsea Hospital and diagnosed with COVID-19. During his stay, he received five doses of remdesivir. At least two doses belonged to contaminated lots.
Days later, Mr. Nowacki experienced his first massive stroke. On Nov. 24 Mr. Nowacki was released to a skilled nursing facility and began developing hematomas and swelling on his hands, face, and arms. He was readmitted to Henry Ford Hospital where his “symptoms remained a mystery to physicians.”
Mr. Nowacki experienced a second stroke on Dec. 16 that left him bedridden and in need of permanent round-the-clock care for the rest of his life.
The tragedy and loss can’t be measured, but if they win, a Jury must work that out. I’m wondering whether, in the course of the case, anyone will even bother to point out that Remdesivir doesn’t even work on COVID-19 and may make it worse.
WHO has issued a conditional recommendation against the use of remdesivir in hospitalized patients, regardless of disease severity, as there is currently no evidence that remdesivir improves survival and other outcomes in these patients.
The WHOs down in Whoville didn’t get the gumption to make this admission until late 2022, but the evidence started piling up when it got the green light in May 2020. But it was so damn expensive that no one could bring themselves to stop the money train.
People died.
No one can sue for that, it seems, but Glass particles may have been present in as many as 55,000 doses recalled by the manufacturer (Gilead). What remains to be seen is whether a court or a jury will view accidental contamination as willful misconduct, assuming some other judge, upon appeal, doesn’t decide that Dan Nowacki does not have standing to sue.
HT | Epoch Times
